Vardiman JW, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. ed Swerdlow S.H, et al, p85-86, International Agency for Research on Cancer, Lyon 2008.
Hasserjian RP, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. ed Swerdlow S.H, et al, p102, International Agency for Research on Cancer, Lyon 2008.
Ingram W, et al: The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow. Leukemia 20: 1319-1321, 2006.
Patmaik MM, et al: WHO-defined ‘myelodysplastic syndrome with isolated del (5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutation. Leukemia 24: 1283-1289, 2010.
Arber DA, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. ed Swerdlow S.H, et al, p124-126, International Agency for Research on Cancer, Lyon 2008.